Offer - Urjas Oil for just ₹ 1 X
Gemibine is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer. Secondary and off-label uses of Gemibine have also been mentioned below.
The correct dosage of Gemibine depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Gemibine as well, which are listed below. Usually, these side effects of Gemibine go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Gemibine has a Unknown effect for pregnant women and Severe effect on lactating mothers. Further, the section on Gemibine related warnings talks about Gemibine's effects on the liver, heart and kidney.
Gemibine is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Infections are examples of such conditions. Some other conditions that can be affected by Gemibine are listed in the contraindications section below.
Drug reaction of Gemibine with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Gemibine, it is important to know that it is safe while driving, and is habit-forming.
Gemibine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Adult |
|
Geriatric |
|
Is the use of Gemibine safe for pregnant women?
No research has not been done till date on the safety of Gemibine for pregnant women. So its effects on pregnant women are unknown.
Is the use of Gemibine safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Gemibine. It should only be taken after medical advice.
What is the effect of Gemibine on the Kidneys?
Very few cases of side effects of Gemibine on kidney have been reported.
What is the effect of Gemibine on the Liver?
There may be an adverse effect on the liver after taking Gemibine. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Gemibine on the Heart?
Gemibine has very mild side effects on the heart.
Gemibine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemibine unless your doctor advises you to do so -
Is this Gemibine habit forming or addictive?
Gemibine does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Gemibine will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Gemibine only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Gemibine for mental disorders.
Interaction between Food and Gemibine
Due to a lack of research, nothing can be said about the consequences of taking Gemibine together with food.
Interaction between Alcohol and Gemibine
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Gemibine.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gemzar® (Gemcitabine HCl)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 612-614